On Tuesday, February 12, Tom Whitehead traveled to Greensboro, NC to speak and share his story at Corning Life Sciences global sales meeting, followed by a Q&A with Chris Mach, Corning's Director of Cell and Gene Therapy Strategy.
During the week of January 22-24, 2019 we had the honor to attend the co-located Phacilitate Leaders World and World Stem Cell Summit 2019 conferences in Miami, Florida and host a yacht party fundraiser in partnership with Phacilitate — which raised a total $17,350!
It's our anniversary! It has been four years to the date since we first launched the Emily Whitehead Foundation. Thank you to all who have supported us thus far in our journey.
On January 3, 2019, we began the new year by joining members of our local community at the 4th Annual Take Down Cancer Event benefitting the Emily Whitehead Foundation. Thanks to the combined fundraising efforts of the Philipsburg-Osceola and Clearfield school districts and high school wrestling clubs, this year's event raised a total $11,205 to help further childhood cancer research!
On November 2, 2018 Nicole Gularte became the very first patient in a brand new CART-22 clinical trial at Penn Medicine — following a relapse of her cancer after participating in the CTL019 CAR-T cell therapy trial in October 2016. Today, Nicole is an eight-time cancer survivor and once again in remission thanks to CAR-T cell therapy research.